Press release
Idiopathic Inflammatory Myopathy Treatment Market Worth $930.6 Million by 2026; Rising Demand for Innovative Therapeutics to Boost Growth: Fortune Business Insights™
The global idiopathic inflammatory myopathy treatment market size is projected to reach USD 930.6 million by 2026, thereby exhibiting a CAGR of 4.6% during the forecast period. However, the market was worth USD 652.3 million in 2018. Fortune Business Insights™ published this information in an upcoming report, titled, “Idiopathic Inflammatory Myopathy Treatment Market Size, Share & Industry Analysis, By Disease Type (Dermatomyositis (DM), Polymyositis (PM), Inclusion Body Myositis (IBM), Necrotizing Autoimmune Myopathy (NAM), Others), By Treatment (Corticosteroids, Immunosuppressants, Intravenous Immunoglobulins, Others), By Route of Administration (Oral, Intravenous, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026.”Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/idiopathic-inflammatory-myopathy-treatment-market-100198
Highlights of the Report:
In-depth analysis of various insights, namely, Idiopathic Inflammatory Myopathy Treatment Market trends, growth drivers, opportunities, and other related challenges.
Comprehensive details of key market players, their core competencies, and Idiopathic Inflammatory Myopathy Treatment Market share.
The potency of suppliers and buyers to make better business decisions.
Lists out the market size in terms of volume.
Key Players Operating in The Idiopathic Inflammatory Myopathy Treatment Market Include:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
Grifols, S.A.
ImmunoForge
Shire (Takeda Pharmaceutical Company Limited)
ORPHAZYME A/S
Mylan N.V.
Biotest AG
Pfizer Inc.
CSL Limited (CSL Behring)
LFB Group
Kedrion S.p.A.
Other key market players
Quick Buy
https://www.fortunebusinessinsights.com/checkout-page/100198
Urgent Need for Modern Therapeutics to Boost Growth
Nowadays, numerous new, modern therapies are emerging across the world. The demand for more effective therapeutics is also rising day by day. Earlier, the traditional treatment options had limitations for the doses of immunosuppressants and glucocorticoids. They could be used up to a certain extent. However, today’s innovative therapeutic options help in treating a wide range of myositis.
Moreover, as more and more difficult-to-treat cases of idiopathic inflammatory myopathy increased, mankind realized the dire need for state-of-the-art therapies. It further created a high unmet demand for treatment options. It is expected to be one of the most crucial idiopathic inflammatory myopathy treatment market growth drivers.
Polymyositis Segment to Lead: Rising Prevalence of this Myopathy
By disease type, the market is divided into necrotizing autoimmune myopathy (NAM), dermatomyositis (DM), inclusion body myositis (IBM), polymyositis (PM), and others. Out of these, the PM segment had acquired 44.4% idiopathic inflammatory myopathy treatment market share in 2018. It is expected to retain its leading position throughout the forecast period. It is likely to occur as PM is considered to be one of the highly occurring forms of myositis. It is also capable of causing disability in those people who do not seek medical treatment immediately. Besides, increasing prevalence of PM worldwide and its presence in numerous clinical pipeline by industry giants would propel the growth of this segment. The other segments have also contributed to the steady growth of the market.
Detailed Table of Content:
Introduction
Research Scope
Market Segmentation
Research Methodology
Definitions and Assumptions
Executive Summary
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Key Insights
Prevalence of Idiopathic Inflammatory Myopathy by Key Countries, 2018
Advancements in Research & Development of Treatment Options
Pipeline Analysis
Key Industry Developments
New Product Launches
Global Idiopathic Inflammatory Myopathy Treatment Market Analysis, Insights and Forecast, 2015-2026
Key Findings / Summary
Market Analysis, Insights and Forecast – By Disease Type
Dermatomyositis (DM)
Polymyositis (PM)
Inclusion Body Myositis (IBM)
Necrotizing Autoimmune Myopathy (NAM)
Others
Market Analysis, Insights and Forecast – By Treatment
Corticosteroids
Immunosuppressants
Intravenous Immunoglobulins
Others
Market Analysis, Insights and Forecast – By Route of Administration
Oral
Intravenous
Others
Market Analysis, Insights and Forecast – By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Market Analysis, Insights and Forecast – By Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
ToC Continue…
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/idiopathic-inflammatory-myopathy-treatment-market-100198
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Linkedin | Twitter | BLogs
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Idiopathic Inflammatory Myopathy Treatment Market Worth $930.6 Million by 2026; Rising Demand for Innovative Therapeutics to Boost Growth: Fortune Business Insights™ here
News-ID: 2544781 • Views: …
More Releases from Fortune Business Insights
Freeze-Dried Fruits & Vegetables Market Poised for Remarkable Growth, set to Rea …
The global market for freeze-dried fruits and vegetables was valued at USD 8.21 billion in 2023. It is anticipated to expand from USD 8.75 billion in 2024 to USD 14.87 billion by 2032, registering a compound annual growth rate (CAGR) of 6.86% throughout the forecast period. In 2023, Europe held the largest share of the market, accounting for 93.4%.
In addition, the U.S. market for freeze-dried fruits and vegetables is expected…
Curcumin Market Poised for Remarkable Growth, set to Reach USD 205.48 million by …
The global curcumin market was valued at USD 93.24 million in 2024 and is expected to grow from USD 101.67 million in 2025 to USD 205.48 million by 2032, reflecting a CAGR of 10.57% throughout the forecast period. In 2024, Asia Pacific emerged as the leading region, accounting for 31.63% of the global market share. The U.S. market for curcumin is projected to grow significantly as well, reaching approximately USD…
Gluten free Food Market Poised for Remarkable Growth, set to Reach USD 13.81 bil …
The global gluten-free food market size was valued at USD 6.74 billion in 2023 and is forecasted to rise from USD 7.28 billion in 2024 to USD 13.81 billion by 2032, registering a CAGR of 8.33% over the 2024-2032 period.
In 2023, North America held the largest share of the gluten-free food market at 51.63%. Additionally, the gluten-free food market in the U.S. is expected to see considerable expansion, potentially…
Functional Food and Beverage Market Poised for Remarkable Growth, set to Reach U …
The global functional food and beverage market size reached USD 364.18 billion in 2024. It is expected to expand from USD 398.81 billion in 2025 to USD 793.60 billion by 2032, reflecting a CAGR of 10.33% during the forecast period (2025-2032).
In 2024, the Asia Pacific region led the functional food and beverage industry, accounting for 39.45% of the market share. In the United States, the functional foods segment is anticipated…
More Releases for Myopathy
Myotubular Myopathy Treatment Market 2021 to Perceive Biggest Trend and Opportun …
A worldwide Myotubular Myopathy Treatment Market research report provides insights about the business scenario with which business strategies can be built to thrive in the industry. Numerous factors have been studied in this report that has an influence on the market and industry. These factors can be listed as industry insight and critical success factors (CSFs), market segmentation, value chain analysis, industry dynamics, market drivers, market restraints, key opportunities,…
Mitochondrial Myopathy Diagnosis & Treatment Market Size - Industry Growth Repor …
QY Research has made a brilliant attempt to elaborately and meticulously analyze the global Mitochondrial Myopathy Diagnosis & Treatment market in its latest report. All of the market forecasts presented in the report are authentic and reliable.
Los Angeles, United State, –– The report is an all-inclusive research study of the global Mitochondrial Myopathy Diagnosis & Treatment market taking into account the growth factors, recent trends, developments, opportunities, and competitive landscape.…
Global Mitochondrial Myopathy Diagnosis & Treatment Market Analysis & Forecast 2 …
Mitochondrial Myopathy Diagnosis & Treatment Market 2020 comprises a detailed survey of the Mitochondrial Myopathy Diagnosis & Treatment Market size, share, trends, extension, consumption, and share, segments, application and Forecast 2025.
Global "Mitochondrial Myopathy Diagnosis & Treatment" Market 2020-2025 Report contains all demographic as well as analytical data regarding market review, growth, demand, and budget analysis. The report mainly highlights the significant trends of the Mitochondrial Myopathy Diagnosis & Treatment market…
Mitochondrial Myopathy Market Overview by Companies, Drug Profile and Developmen …
Mitochondrial Myopathies are the diseases that affect a specific part of the cells in the body. Specifically, mitochondrial diseases affect the mitochondria, which is the tiny energy factories found inside almost all our cells. The symptoms of Mitochondrial Myopathies are breathing issues, heart related issues, kidney problems, gastrointestinal problems or diabetes. It is a rare mutational disease and at present there is no concrete treatment available in the market for…
Mitochondrial Myopathy Pharmaceutical and Healthcare Analysis Information
Mitochondrial Myopathies are the diseases that affect a specific part of the cells in the body. Specifically, mitochondrial diseases affect the mitochondria, which is the tiny energy factories found inside almost all our cells. The symptoms of Mitochondrial Myopathies are breathing issues, heart related issues, kidney problems, gastrointestinal problems or diabetes. It is a rare mutational disease and at present there is no concrete treatment available in the market for…
Mitochondrial Myopathy Diagnosis & Treatment Market – Identify Opportunities a …
Mitochondrial myopathies are related to mitochondrial illnesses which can be due to nice nuclear DNA deletions and mutations. Mitochondrial myopathies affect mitochondria that is chargeable for power production within a cellular related to mitochondrial sickness. As a result, they reason low electricity and unfastened radical manufacturing which ends up in a spread of signs and symptoms and signs.
The Global Mitochondrial Myopathy Diagnosis & Treatment Market is expected to reach $…
